Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$309,372,018
+$31,092,679 QoQ
Shares Held
1,974,043
+8.4% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#18
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JONES FINANCIAL COMPANIES LLLP holds $2,915,385,555 across 19 Drug Manufacturers - General names. NVS ranks #5 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
746,099 | $894,893,598 | |
| 2 | JNJ |
Johnson & Johnson
|
1,814,780 | $460,899,675 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,548,737 | $327,512,704 | |
| 4 | AZN |
Astrazeneca PLC
|
1,670,876 | $316,831,506 | |
| 5 | NVS |
Novartis AG
This page
|
1,974,043 | $309,372,018 | |
| 6 | ABBV |
AbbVie Inc.
|
988,813 | $248,824,903 | |
| 7 | PFE |
Pfizer Inc
|
4,638,683 | $111,699,485 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
502,809 | $63,524,888 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $309,372,018 | 1,974,043 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $278,279,339 | 1,821,796 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,061,398 | 196,282 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $23,797,880 | 185,573 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $20,948,766 | 173,116 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $17,329,007 | 155,445 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $13,313,856 | 136,819 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $11,629,096 | 101,105 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,283,567 | 68,416 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,221,393 | 43,641 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,181,873 | 41,417 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,155,888 | 40,800 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,604,018 | 45,625 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,410,848 | 47,944 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,889,354 | 53,895 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,431,382 | 58,300 | Shares | Defined | 2022-11-03 | |
| 2022-06-30 | $5,864,099 | 69,373 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $8,491,655 | 96,771 | Shares | Defined | 2022-05-02 | |
| 2021-12-31 | $12,478,819 | 142,664 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $11,733,385 | 143,475 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $13,295,218 | 145,717 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $12,017,120 | 140,584 | Shares | Defined | 2021-04-30 | |
| 2020-12-31 | $13,124,447 | 138,986 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $11,711,859 | 134,681 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $11,289,742 | 129,262 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $10,684,942 | 129,593 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||